CHI3L1 and Alzheimer disease: CHI3L1 levels may be important for the evaluation of cerebral inflammatory activity in AD patients, being increased in the CSF of MCI-AD patients compared with stable MCI, CHI3L1 could be used as a reliable biomarker for the prognosis of MCI and the likelihood of progression to AD (Figure 2) [70].